-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On March 15, it was learned from the Institute of Microbiology of the Chinese Academy of Sciences that the European Medicines Agency’s Committee for Medicinal Products for Human Use has recently allowed EU member states to use the combination therapy of monoclonal antibodies LY-CoV555 and LY-CoV016 in public health emergencies (" "Antibody cocktail" therapy) to deal with patients with new coronary pneumonia infection, among which LY-CoV016 was jointly developed by the Institute of Microbiology, Chinese Academy of Sciences and Junshi Bio.